Buchanan, Robert W <br/><br/>
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.  [electronic resource] 

 -  Biological psychiatry  Mar 2011 
 - 442-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2010.09.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cognition--drug effects<br/>Cognition Disorders--drug therapy<br/>Diagnostic and Statistical Manual of Mental Disorders<br/>Double-Blind Method<br/>Female<br/>GABA Agonists--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Psychiatric Status Rating Scales<br/>Pyridazines--therapeutic use<br/>Receptors, GABA-A--drug effects<br/>Schizophrenia--drug therapy<br/>Schizophrenic Psychology<br/>Treatment Outcome<br/>Triazoles--therapeutic use<br/>Young Adult